What is the address of HEALTH CONCEPT AND INNOVATION?

The registered office of HEALTH CONCEPT AND INNOVATION is located at Tongersesteenweg 28A, 3730 Bilzen-Hoeselt.

Is HEALTH CONCEPT AND INNOVATION still active?

Yes. According to the CBE (16 September 2026) HEALTH CONCEPT AND INNOVATION is active, legal situation “Normale toestand”, started on 23 September 2009.

Is HEALTH CONCEPT AND INNOVATION registered on Peppol?

No, HEALTH CONCEPT AND INNOVATION is currently not registered on the Peppol network.

What is the enterprise number of HEALTH CONCEPT AND INNOVATION?

The enterprise number of HEALTH CONCEPT AND INNOVATION is BE0818832626.

When was HEALTH CONCEPT AND INNOVATION founded?

HEALTH CONCEPT AND INNOVATION was founded on 23 September 2009.

Who are the directors of HEALTH CONCEPT AND INNOVATION?

According to the 2025 annual accounts, the directors of HEALTH CONCEPT AND INNOVATION are: CARLO JEUNEN.

Is HEALTH CONCEPT AND INNOVATION a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 23 September 2009; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did HEALTH CONCEPT AND INNOVATION make in 2025?

HEALTH CONCEPT AND INNOVATION recorded a loss after taxes of € 4,792 in financial year 2025.

What is the revenue of HEALTH CONCEPT AND INNOVATION?

As a small company, HEALTH CONCEPT AND INNOVATION is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € -4,294.

HEALTH CONCEPT AND INNOVATION (Private Limited)

Dossier HEALTH CONCEPT AND INNOVATION, printed on 16 September 2026 from databakkes.be/en/0818832626/health-concept-and-innovation. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2024 and 2025.
Tight liquidity NBB

Cash and receivables cover 52 % of short-term debt in 2025; threshold 65 %.
Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

HEALTH CONCEPT AND INNOVATION from Bilzen-Hoeselt, company number BE0818832626, closed financial year 2025 with a result of € -4,792 after tax. For that financial year HEALTH CONCEPT AND INNOVATION recorded a gross margin of € -4,294 and equity of € -10,081. Compared with financial year 2024, the result moved from € -1,778 to € -4,792. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on March 25, 2026.

What it is worth Caution

€ -10,081

▼ € 4,792 vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -4,792

▼ 169 % more loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 315

▼ 59% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -28,681.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 13,508

▲ 43% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ -1,433 Gross margin 2022: € -1,433 First fiscal year in the series	€ -1,909 Gross margin 2023: € -1,909 ▼ € 476 vs 2022 (€ -1,433) Unfavourable step	€ -1,332 Gross margin 2024: € -1,332 ▲ € 577 vs 2023 (€ -1,909) Favourable step	€ -4,294 Gross margin 2025: € -4,294 ▼ € 2,962 vs 2024 (€ -1,332) Unfavourable step	▼ € 2,962
Profit after taxes	€ -1,843 Profit after taxes 2022: € -1,843 First fiscal year in the series	€ -2,319 Profit after taxes 2023: € -2,319 ▼ € 476 vs 2022 (€ -1,843) Unfavourable step	€ -1,778 Profit after taxes 2024: € -1,778 ▲ € 541 vs 2023 (€ -2,319) Favourable step	€ -4,792 Profit after taxes 2025: € -4,792 ▼ € 3,014 vs 2024 (€ -1,778) Unfavourable step	▼ € 3,014
Equity	€ -1,192 Equity 2022: € -1,192 First fiscal year in the series	€ -3,511 Equity 2023: € -3,511 ▼ € 2,319 vs 2022 (€ -1,192) Unfavourable step	€ -5,289 Equity 2024: € -5,289 ▼ € 1,778 vs 2023 (€ -3,511) Unfavourable step	€ -10,081 Equity 2025: € -10,081 ▼ € 4,792 vs 2024 (€ -5,289) Unfavourable step	▼ € 4,792
Total debts	€ 11,433 Total debts 2022: € 11,433 First fiscal year in the series	€ 13,303 Total debts 2023: € 13,303 ▲ 16% vs 2022 (€ 11,433) Unfavourable step	€ 13,535 Total debts 2024: € 13,535 ▲ 2% vs 2023 (€ 13,303) Unfavourable step	€ 17,873 Total debts 2025: € 17,873 ▲ 32% vs 2024 (€ 13,535) Unfavourable step	▲ 32%
Cash	€ 1,009 Cash 2022: € 1,009 First fiscal year in the series	€ 529 Cash 2023: € 529 ▼ 48% vs 2022 (€ 1,009) Unfavourable step	€ 769 Cash 2024: € 769 ▲ 45% vs 2023 (€ 529) Favourable step	€ 315 Cash 2025: € 315 ▼ 59% vs 2024 (€ 769) Unfavourable step	▼ 59%
Retained profit	€ -19,792 Retained profit 2022: € -19,792 First fiscal year in the series	€ -22,111 Retained profit 2023: € -22,111 ▼ € 2,319 vs 2022 (€ -19,792) Unfavourable step	€ -23,889 Retained profit 2024: € -23,889 ▼ € 1,778 vs 2023 (€ -22,111) Unfavourable step	€ -28,681 Retained profit 2025: € -28,681 ▼ € 4,792 vs 2024 (€ -23,889) Unfavourable step	▼ € 4,792
Balance sheet total	€ 10,241 Balance sheet total 2022: € 10,241 First fiscal year in the series	€ 9,792 Balance sheet total 2023: € 9,792 ▼ 4% vs 2022 (€ 10,241) Unchanged	€ 8,246 Balance sheet total 2024: € 8,246 ▼ 16% vs 2023 (€ 9,792) Unchanged	€ 7,791 Balance sheet total 2025: € 7,791 ▼ 6% vs 2024 (€ 8,246) Unchanged	▼ 6%

Key figures of HEALTH CONCEPT AND INNOVATION, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 30 April 2027.

What happened to HEALTH CONCEPT AND INNOVATION?

What happened at HEALTH CONCEPT AND INNOVATION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Mar 25, 2026 New annual accounts for financial year 2025: loss of € 4,792. Source: NBB ↗
Sep 23, 2009 New establishment in Bilzen-Hoeselt. KBO
2009 CARLO JEUNEN became a director. NBB
Sep 23, 2009 Start of the company according to the CBE. KBO

In short

From € 1,843 loss in 2022 to € 4,792 loss in 2025.

Original PDFs at the National Bank ↗

A new publication or filing at HEALTH CONCEPT AND INNOVATION? We notify you, reason included.

Follow HEALTH CONCEPT AND INNOVATION

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

CARLO JEUNEN

HEALTH CONCEPT AND INNOVATION

QUATRO

Behind HEALTH CONCEPT AND INNOVATION is CARLO JEUNEN. CARLO JEUNEN is also behind QUATRO.

See the full network in the app

Directors

According to the 2025 annual accounts

CARLO JEUNEN

Director

Also active at: QUATRO

since 2009

Establishments

Establishment units

Physical locations of this company

Registered office

Tongersesteenweg 28A

3730 Bilzen-Hoeselt

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 3 companies are registered at this address.

All companies at this address →

SHUMI

€ 112,036 gross margin · 2025

QUATRO same network

€ 274,464 revenue · 2025

ASTRIOS SALES

€ 912,510 revenue · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0818.832.626
VAT number: BE 0818.832.626
Registered office: Tongersesteenweg 28A, 3730 Bilzen-Hoeselt
Names & denominations: HEALTH CONCEPT AND INNOVATION · HECO-INOV
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 23 September 2009
Peppol: Not registered

View on CBE Public ↗ Annual accounts (NBB) ↗